ClinicalTrials.Veeva

Menu

Ceramic Modular Dual Mobility in Primary Total Hip Arthroplasty (THA) (CeMoD-prime)

Aesculap logo

Aesculap

Status

Enrolling

Conditions

Coxarthrosis; Primary

Treatments

Device: Standard Acetabular component
Device: Dual Mobility Cup

Study type

Interventional

Funder types

Industry

Identifiers

NCT05547984
AAG-G-H-2203

Details and patient eligibility

About

A randomized controlled trial comparing modular dual mobility inserts with ceramic multilayer coating versus standard polyethylene inserts for primary THA in a cementless acetabular cup

Full description

The aim of this study is to show in a randomized controlled trial that cobalt and chromium ion serum levels are comparable to the metal ion levels in patients with standard articulation with metal head. The metal on polyethylene articulation is accepted as standard articulation since many decades, and which is currently in the Czech Republic the most used combination. Most studies which focused on the topic of metal ion release from modular dual mobility systems do not present results of a control group with standard articulation hip implants.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Primary coxarthrosis patients indicated for cementless total hip arthroplasty
  • Written informed patient consent

Exclusion criteria

  • Hip trauma or revision surgery
  • Rheumatoid or neurologic disease
  • BMI >35
  • Ongoing oncologic therapy
  • Preoperatively elevated Co or Cr serum levels >1.0 µg/L
  • Patients with other joint implants, or anticipated need for another joint replacement surgery within the study period
  • Acetabular cup size <52 expected
  • Patients not able to mentally or physically comply with the study demands and follow-up visits
  • Patients <18 years at surgery
  • Pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Dual Mobility Cup
Experimental group
Description:
dual mobility articulation
Treatment:
Device: Dual Mobility Cup
Standard Acetabular component
Active Comparator group
Description:
standard articulation with polyethylene + vitamin E inlay and metal head
Treatment:
Device: Standard Acetabular component

Trial contacts and locations

1

Loading...

Central trial contact

Stefan Maenz, Dr.; Lutz Dreyer, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems